Lightox Competitors and Similar CompaniesClear all
Lightox's competitors and similar companies include Legend Biotech, Rein Therapeutics, Ikena Oncology and Antikor.
 Legend Biotech Legend Biotech is a biopharmaceutical company engaged in the discovery and development of cell therapies for oncology and other indications.
|  Rein Therapeutics Rein Therapeutics (formerly known as Aileron Therapeutics) is a clinical-stage biopharmaceutical company that develops medicines targeting undruggable cancer sites using its proprietary platform of stabilized cell-permeating peptides. |  Ikena Oncology Ikena Oncology (formerly Kyn Therapeutics) is a biotechnology company that discovers and develops biomarker-driven therapies for cancer treatment. |  Antikor Antikor is a biotechnology company that specializes in the discovery and development of small-format antibody-drug conjugates. | ||
Founding Date | Founding Date 2016 | Founding Date 2014 | Founding Date 2005 | Founding Date 2016 | Founding Date 2014 |
Type | Type Private | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Newcastle upon Tyne, GB HQ Stockton On Tees, GB | Locations Somerset, US HQ Ghent, BE Nanjing, CN Hong Kong, HK Dublin, IE Piscataway, US | Locations Watertown, US HQ Boston, US | Locations Boston, US HQ | Locations Stevenage, GB HQ |
Employees | Employees 15 | Employees 2,90012% increase | Employees 838% decrease | Employees 5052% increase | Employees 11 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 8.4 b | Valuation ($) 90.2 m | Valuation ($) 82.5 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $1b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $800k (FY, 2025) | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($296.8m) (FY, 2025) | Net income ($49.9m) (FY, 2025) | Net income ($45.3m) (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 150.5m | Total funding raised $ 112m | Total funding raised $ 49m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Legend Biotech
HQ
Somerset, US
Employees
2,900↑ 12% increase
Legend Biotech is a biopharmaceutical company engaged in the discovery and development of cell therapies for oncology and other indications.
View companyRein Therapeutics
HQ
Watertown, US
Employees
8↓ 38% decrease
Rein Therapeutics (formerly known as Aileron Therapeutics) is a clinical-stage biopharmaceutical company that develops medicines targeting undruggable cancer sites using its proprietary platform of stabilized cell-permeating peptides.
View companyIkena Oncology
HQ
Boston, US
Employees
50
Ikena Oncology (formerly Kyn Therapeutics) is a biotechnology company that discovers and develops biomarker-driven therapies for cancer treatment.
View companyAntikor
HQ
Stevenage, GB
Employees
11
Antikor is a biotechnology company that specializes in the discovery and development of small-format antibody-drug conjugates.
View company